More relevant, in NAFLD patients, the rs1800849 UCP3 -55CT genotype was associated with insulin resistance, adiponectin levels, the presence of moderate-severe steatosis and NASH [167]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.